MX374378B - Mioinositol y probioticos, y uso de estos. - Google Patents

Mioinositol y probioticos, y uso de estos.

Info

Publication number
MX374378B
MX374378B MX2017001632A MX2017001632A MX374378B MX 374378 B MX374378 B MX 374378B MX 2017001632 A MX2017001632 A MX 2017001632A MX 2017001632 A MX2017001632 A MX 2017001632A MX 374378 B MX374378 B MX 374378B
Authority
MX
Mexico
Prior art keywords
infant
probiotics
myoinositol
myo
inositol
Prior art date
Application number
MX2017001632A
Other languages
English (en)
Other versions
MX2017001632A (es
Inventor
Catherine Mace
Florence Budin
Irma Silva ZOLEZZI
Keith Malcolm Godfrey
Philip Newton Baker
Yap Seng Chong
Original Assignee
Soc Des Produits Nestle S A Star
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc Des Produits Nestle S A Star filed Critical Soc Des Produits Nestle S A Star
Publication of MX2017001632A publication Critical patent/MX2017001632A/es
Publication of MX374378B publication Critical patent/MX374378B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/156—Flavoured milk preparations ; Addition of fruits, vegetables, sugars, sugar alcohols or sweeteners
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A23C9/206—Colostrum; Human milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Mioinositol y probióticos previstos para mejorar la composición corporal de un infante, particularmente, para prevenir el exceso de peso y/o para aumentar el % de masa magra de un infante, en donde el mioinositol 54 y los probióticos se administran simultáneamente, de manera separada o en secuencia al infante en el útero y, opcionalmente, además después del nacimiento.
MX2017001632A 2014-08-08 2015-08-06 Mioinositol y probioticos, y uso de estos. MX374378B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14180403 2014-08-08
EP15170915 2015-06-05
PCT/EP2015/068192 WO2016020491A1 (en) 2014-08-08 2015-08-06 Myo-inositol and probiotics, and their use

Publications (2)

Publication Number Publication Date
MX2017001632A MX2017001632A (es) 2017-08-10
MX374378B true MX374378B (es) 2025-03-06

Family

ID=53836571

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017001632A MX374378B (es) 2014-08-08 2015-08-06 Mioinositol y probioticos, y uso de estos.

Country Status (8)

Country Link
EP (1) EP3177154B1 (es)
CN (1) CN106659222A (es)
BR (1) BR112017001097B1 (es)
CA (1) CA2953113C (es)
ES (1) ES2755949T3 (es)
MX (1) MX374378B (es)
PH (1) PH12017500018B1 (es)
WO (1) WO2016020491A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3062287B1 (fr) * 2017-01-27 2021-07-16 Denali Pharma Composition probiotique nutritionnelle et utilisation d'une telle composition pour la fabrication d'un supplement de probiotiques
MX2021001966A (es) * 2018-08-22 2021-05-12 Nestle Sa Composicion que comprende isomeros de inositol y su uso.
US20220287987A1 (en) * 2019-08-26 2022-09-15 Societe Des Produits Nestle S.A. Myo-inositol and the prevention of pprom
BR112022002412A2 (pt) 2019-08-26 2022-06-14 Nestle Sa Mioinositol e a prevenção do nascimento prematuro
TW202327559A (zh) * 2021-12-09 2023-07-16 瑞士商雀巢製品股份有限公司 用於增加母乳微量營養素含量之產前補充劑組成物
WO2024100178A1 (en) * 2022-11-11 2024-05-16 Société des Produits Nestlé S.A. Myo-inositol and the prevention of accelerated growth
USD1131032S1 (en) * 2024-10-17 2026-06-23 Quip NYC Inc. Brush

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW282398B (es) * 1993-12-22 1996-08-01 Bristol Myers Squibb Co
OA13142A (en) * 2002-10-11 2006-12-13 Wyeth Corp Nutritional formulations containing synbiotic substances.
ITRM20040505A1 (it) * 2004-10-15 2005-01-15 Cd Invest Liofilizzati di batteri lattici e bifidobatteri ad alta dispersibilita'.
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
EP2011506A1 (en) * 2007-07-05 2009-01-07 Nestec S.A. Supplementation of maternal diet
EP2452575A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Array of age-tailored nutritional formula with probiotics

Also Published As

Publication number Publication date
WO2016020491A1 (en) 2016-02-11
CN106659222A (zh) 2017-05-10
CA2953113C (en) 2024-04-09
ES2755949T3 (es) 2020-04-24
MX2017001632A (es) 2017-08-10
EP3177154B1 (en) 2019-09-25
CA2953113A1 (en) 2016-02-11
BR112017001097B1 (pt) 2021-11-16
PH12017500018B1 (en) 2023-09-13
BR112017001097A2 (pt) 2017-11-14
PH12017500018A1 (en) 2017-05-15
EP3177154A1 (en) 2017-06-14

Similar Documents

Publication Publication Date Title
PH12015502565B1 (en) Anti-transferrin receptor antibodies and methods of use
MX2021013837A (es) Enfoque de inmunoterapias de combinacion para el tratamiento del cancer.
AR089993A1 (es) Macrociclos peptidomimeticos
MX378273B (es) Compuestos activos hacia bromodominios.
MX2017005977A (es) Anticuerpos biespecificos y metodos de uso en oftalmologia.
BR112017011215A2 (pt) partículas de distribuição de pró-flavorizante
MX2020001201A (es) Anticuerpos anti-activina a y usos de los mismos.
MX379193B (es) Composiciones en solucion solida y su uso en inflamacion cronica.
TN2017000246A1 (en) Anti-c10orf54 antibodies and uses thereof
BR112017001579A2 (pt) anticorpos anti-cd3, anticorpos anti-cd3 ativáveis, anticorpos anti-cd3 multiespecíficos, anticorpos anti-cd3 ativáveis multiespecíficos e métodos de uso dos mesmos
MX363347B (es) Sal de omecamtiv mecarbilo y proceso para preparar la sal.
MX2016008448A (es) Conjugados de var2csa-farmaco.
CL2014001865A1 (es) Compuestos derivados de fosfatos; procedimiento de preparacion; composiciones farmaceuticas que los contienen y uso en el tratamiento del cancer.
PH12017500018B1 (en) Myo-inositol and probiotics, and their use
CL2015002724A1 (es) Métodos para tratar la enfermedad de crohn utilizando un anticuerpo anti-il23
TWD170026S (zh) 容器
PH12016500753B1 (en) Antibodies specific to fcrn
BR112017005314A2 (pt) inibidores de ssao derivados de imidazo[4,5-c]piridina
MY191539A (en) Streptococcal vaccine
CL2015002620A1 (es) Derivados piridin-4-ilo
TWD180370S (zh) 落地式逆滲透淨水器
WO2015153997A3 (en) Notch3 antibodies and uses thereof
MX2019010913A (es) Analogos de deutetrabenazina, su preparacion y uso.
MX2020009966A (es) Formas de dosificacion y usos terapeuticos de la l-4-cloro quinurenina.
PH12016501434A1 (en) Compositions for use in the treatment of allergic conditions

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: SOCIETE DES PRODUITS NESTLE S.A.*

FG Grant or registration